Defence Expo 2018: Ashok Leyland Has Defence Orders Worth More Than Rs 5,000 Crore
Trucks and commercial vehicles manufacturer Ashok Leyland Ltd. has defence orders worth more than Rs 5,000 crore as it bagged a bulk of the contracts in the sector over the last year.
“We have bagged 12 of the 15 contracts over the last one year, amounting to Rs 5,000 crore that needs to be executed in the next five years,” Managing Director Vinod Dasari told BloombergQuint in an interview. Dasari was unveiling new logistics products for the armed forces at the 2018 Defence Expo in Chennai.
Also Read: BEL Crossed Rs 10,000 Crore Revenue In FY18

Ashok Leyland has been working with the armed forces for the last 70 years and has expanded its offerings in the last four years to cater to 20 percent of the needs, Dasari said. It has ventured into armoured vehicles and expanded the range of trucks to as complex as 12x12 to carry missiles, he added.
Also Read: Lockheed Martin Eyes India As Export Hub For F-16s
Nearly 4 percent of the company's revenue, amounting to Rs 800 crore, now comes from defence, Dasari said. The company is focussing primarily on domestic markets but will also explore opportunities to export these products.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.